RMD - ResMed Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 522.09B
Enterprise Value 323.22B
Trailing P/E 52.98
Forward P/E 133.99
PEG Ratio (5 yr expected) 11.82
Price/Sales (ttm)8.18
Price/Book (mrq)10.43
Enterprise Value/Revenue 38.60
Enterprise Value/EBITDA 628.28

Trading Information

Stock Price History

Beta (5Y Monthly) 0.41
52-Week Change 337.46%
S&P500 52-Week Change 324.46%
52 Week High 3153.96
52 Week Low 390.64
50-Day Moving Average 3147.48
200-Day Moving Average 3132.78

Share Statistics

Avg Vol (3 month) 3511.02k
Avg Vol (10 day) 3401.2k
Shares Outstanding 5143.79M
Float 142.37M
% Held by Insiders 11.21%
% Held by Institutions 171.01%
Shares Short (Nov. 29, 2019) 42.31M
Short Ratio (Nov. 29, 2019) 44.56
Short % of Float (Nov. 29, 2019) 41.81%
Short % of Shares Outstanding (Nov. 29, 2019) 41.61%
Shares Short (prior month Oct. 31, 2019) 42.74M

Dividends & Splits

Forward Annual Dividend Rate 41.56
Forward Annual Dividend Yield 41.02%
Trailing Annual Dividend Rate 31.52
Trailing Annual Dividend Yield 31.00%
5 Year Average Dividend Yield 41.65
Payout Ratio 451.72%
Dividend Date 3Dec. 12, 2019
Ex-Dividend Date 4Nov. 6, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Aug. 31, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun. 30, 2019
Most Recent Quarter (mrq)Sep. 30, 2019

Profitability

Profit Margin 15.52%
Operating Margin (ttm)24.56%

Management Effectiveness

Return on Assets (ttm)11.47%
Return on Equity (ttm)20.86%

Income Statement

Revenue (ttm)2.7B
Revenue Per Share (ttm)18.83
Quarterly Revenue Growth (yoy)15.80%
Gross Profit (ttm)1.54B
EBITDA 821.28M
Net Income Avi to Common (ttm)419M
Diluted EPS (ttm)2.90
Quarterly Earnings Growth (yoy)13.60%

Balance Sheet

Total Cash (mrq)172.15M
Total Cash Per Share (mrq)1.2
Total Debt (mrq)1.31B
Total Debt/Equity (mrq)61.66
Current Ratio (mrq)2.11
Book Value Per Share (mrq)14.73

Cash Flow Statement

Operating Cash Flow (ttm)573.29M
Levered Free Cash Flow (ttm)496.76M